Beta Bionics
BBNX
13.36
+0.04
+0.30%
Beta Bionics
US · BBNX
#3406 by market cap
Listed 2025
13.36
+0.04
+0.30%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C-
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: BofA Securities moved from Buy to Hold on 2026-02-17.
Analyst consensus 12 analysts
Buy
Avg price target 25.36 +89.8%
Price target rangecurrent 13.36
Low18.00
Avg25.36
High30.00
Buy 75%
Hold 25%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-29 | Barclays | -- | Buy | 30.00 |
| 2026-10-28 | Wells Fargo | -- | Buy | 28.00 |
| 2026-10-28 | Piper Sandler | -- | Buy | 24.00 |
| 2026-10-28 | Stifel | -- | Buy | 22.00 |
| 2026-10-27 | BofA Securities | -- | Hold | 22.00 |
| 2026-10-12 | Jefferies | -- | Buy | 30.00 |
| 2026-10-06 | Barclays | -- | Buy | 30.00 |
| 2026-09-24 | Truist Financial | -- | Buy | 28.00 |
| 2026-09-23 | Wells Fargo | -- | Buy | 28.00 |
| 2026-09-22 | Lake Street | -- | Buy | 25.00 |
| 2026-09-18 | Lake Street | -- | Buy | 25.00 |
| 2026-09-17 | Leerink Partners | -- | Buy | 27.00 |
| 2026-09-16 | Leerink Partners | -- | Buy | 27.00 |
| 2026-09-15 | UBS | -- | Buy | 25.00 |
| 2026-09-15 | Truist Financial | -- | Buy | 23.00 |
| 2026-09-15 | Stifel | -- | Buy | 22.00 |
| 2026-09-14 | TD Cowen | -- | Hold | 18.00 |
| 2026-09-14 | William Blair | -- | Hold | -- |
| 2026-09-14 | UBS | -- | Buy | 25.00 |
| 2026-09-14 | BofA Securities | -- | Hold | 20.00 |
| 2026-09-14 | Truist Financial | -- | Buy | -- |
| 2026-09-14 | Leerink Partners | -- | Buy | 27.00 |
| 2026-08-21 | William Blair | -- | Hold | -- |
| 2026-08-11 | BofA Securities | -- | Hold | 18.00 |
| 2026-07-30 | Piper Sandler | -- | Buy | 20.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-02-17 | BofA Securities | Buy → Hold | 28.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-27 | After close | ±21.71% | -16.55% (in line) |
| 2026/Q2 | 2026-07-29 | After close | ±24.22% | -5.93% (in line) |
| 2026/Q1 | 2026-04-21 | After close | ±39.89% | -0.57% (in line) |
| 2025/Q4 | 2026-02-17 | After close | ±15.60% | -2.58% (in line) |
| 2025/Q3 | 2025-10-28 | After close | -- | +10.34% |
| 2025/Q2 | 2025-07-29 | After close | -- | +14.32% |
| 2025/Q1 | 2025-05-06 | After close | -- | +26.61% |
| 2024/Q4 | 2025-03-25 | After close | -- | -13.60% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Beta Bionics discussion 0 comments